Product image of Linezolid Polpharma (Linezolid) supplied by GNH India

Linezolid Polpharma

Active Ingredient:
Linezolid
Origin:
EU

Linezolid Polpharma (Linezolid)

Linezolid, the active ingredient in Linezolid Polpharma, is an oxazolidinone presented as an intravenous injection for hospital use. It treats serious Gram‑positive bacterial infections, including methicillin‑resistant Staphylococcus aureus (MRSA), community‑acquired bacterial pneumonia, and skin and soft‑tissue infections.

GNH India supplies Linezolid Polpharma as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals worldwide.

Manufacturer / TM Owner

Zaklady Farmaceutyczne Polpharma S.A.

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

A minimum order value applies. Our team will confirm the exact amount or quantity after reviewing your requirements.

Indications & Clinical Uses

Linezolid is an oxazolidinone antibiotic used to treat infections caused by Gram‑positive bacteria.

  • Methicillin‑resistant Staphylococcus aureus (MRSA): effective for bloodstream, skin and lung infections caused by MRSA.
  • Community‑acquired bacterial pneumonia: improves clinical outcomes in adults with pneumonia due to susceptible organisms.
  • Skin and soft‑tissue infections: resolves infections caused by susceptible Gram‑positive pathogens.
  • Hospital‑acquired pneumonia: used when other agents are ineffective against resistant Gram‑positive organisms.

How It Works

  • Linezolid inhibits bacterial protein synthesis by binding to the 50S ribosomal subunit, preventing the formation of the initiation complex required for translation. This action blocks the production of essential proteins, leading to bacteriostatic activity against susceptible Gram‑positive organisms.

Side Effects

Linezolid may cause a range of adverse reactions, which are categorized by frequency and severity.

Common Side Effects

  • Nausea: mild to moderate gastrointestinal upset.
  • Diarrhea: loose stools occurring during therapy.
  • Headache: transient cranial discomfort.
  • Vomiting: occasional emesis.
  • Metallic taste: altered taste perception.
  • Rash: mild skin erythema.

Serious or Rare Side Effects

  • Thrombocytopenia: significant drop in platelet count.
  • Anemia: reduced red blood cell levels.
  • Peripheral neuropathy: nerve pain or sensory changes.
  • Serotonin syndrome: potentially life‑threatening reaction when combined with serotonergic agents.
  • Lactic acidosis: rare metabolic disturbance.
  • Optic neuritis: inflammation of the optic nerve affecting vision.

Precautions & Warnings

When using Linezolid, clinicians should consider several precautionary measures to minimize risk.

  • Renal impairment: monitor renal function and adjust therapy as needed.
  • Hepatic impairment: assess liver enzymes regularly.
  • Concomitant serotonergic agents: avoid or closely monitor for serotonin syndrome.
  • Hematologic monitoring: perform regular complete blood counts to detect thrombocytopenia or anemia.
  • Pregnancy: safety unknown; use only if benefits outweigh potential risks.
  • Store at 2-8°C: keep refrigerated, protect from light, do not freeze.

Avoid Interactions

Linezolid can interact with other medicines, requiring attention to avoid reduced efficacy or increased toxicity.

Major Interactions (Avoid)

  • Selective serotonin reuptake inhibitors (SSRIs) and other serotonergic agents: risk of serotonin syndrome.
  • Monoamine oxidase inhibitors (MAOIs): risk of hypertensive crisis and serotonin syndrome.
  • Rifampin: may significantly reduce linezolid plasma concentrations.

Moderate Interactions (Monitor Closely)

  • Warfarin: may increase INR; monitor coagulation parameters.
  • Non‑steroidal anti‑inflammatory drugs (NSAIDs): may increase bleeding risk.
  • Carbamazepine or phenytoin: may lower linezolid levels; monitor therapeutic response.

Frequently Asked Questions

Linezolid Polpharma is an intravenous oxazolidinone antibiotic indicated for serious Gram‑positive bacterial infections such as methicillin‑resistant Staphylococcus aureus (MRSA), community‑acquired bacterial pneumonia, and skin and soft‑tissue infections. It is administered in hospital settings where rapid, reliable antimicrobial therapy is required.

Linezolid acts by binding to the bacterial 50S ribosomal subunit, blocking the formation of the initiation complex needed for protein synthesis. This inhibition halts bacterial growth, providing a bacteriostatic effect against susceptible Gram‑positive organisms.

The exact dose is determined by the prescribing clinician based on the type and severity of infection, patient weight, renal and hepatic function, and local guidelines. In many adult cases, a common regimen is 600 mg administered intravenously every 12 hours, but the prescriber sets the final schedule.

Safety data for linezolid during pregnancy and lactation are limited, and the pregnancy category is listed as unknown. It should only be used when the potential benefit to the mother outweighs any possible risk to the fetus or infant, and under close medical supervision.

To place an order, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies, and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details (including cold‑chain if needed), and the necessary import documentation.

The primary alternative for many Gram‑positive infections is vancomycin. Linezolid offers oral and IV formulations, excellent lung penetration, and activity against some vancomycin‑resistant strains, while vancomycin requires therapeutic drug monitoring and may cause nephrotoxicity. Choice depends on infection site, resistance patterns, and patient-specific factors.

Linezolid Polpharma for injection should be stored at 2‑8 °C (refrigerated). Keep the vials in their original packaging, protect from light, and avoid freezing or shaking the solution. Once removed from refrigeration, use according to the manufacturer’s stability guidelines.

The product is given by intravenous infusion. Typically, the reconstituted solution is infused over 30 to 60 minutes, depending on clinical protocol. Administration should be performed by qualified healthcare personnel in a setting equipped for IV therapy.

Serious adverse events include thrombocytopenia, anemia, peripheral neuropathy, serotonin syndrome (especially when combined with serotonergic drugs), lactic acidosis, and optic neuritis. Patients should be monitored regularly for blood‑count changes, neurological symptoms, and signs of metabolic disturbances.

Linezolid is contraindicated in individuals with known hypersensitivity to linezolid or any component of the formulation. It should also be avoided in patients currently taking monoamine oxidase inhibitors, and used with caution in pregnant or breastfeeding women, unless the therapeutic benefit justifies potential risks.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Related Products

Other formulations containing Linezolid

A

A
A

A
A

A
A

A

Browse all products →

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Regulatory recognitions

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.

SGS GSDP Certification

GSDP Compliant from SGS

URS ISO 9001

URS ISO 9001 Certification

FDA Maharashtra

Licensed by FDA Maharashtra

IEC License DGFT

IEC License issued by DGFT